Sign up for free insights newsletter
SS

Sysmex Corporation

SSMXFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$8.43
+0.00%
End of day
Market Cap

$5.25B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

289.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.08-1.08
Calmar-2.28-2.28
Sharpe-0.91-0.91
Omega0.620.62
Martin-5.92-5.92
Ulcer5.655.65

Sysmex Corporation (SSMXF) Price Performance

Sysmex Corporation (SSMXF) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $8.43.

Over the past year, SSMXF has traded between a low of $8.43 and a high of $17.31. The stock has lost 48.6% over this period. It is currently 51.3% below its 52-week high.

Sysmex Corporation has a market capitalization of $5.25B and a dividend yield of 289.00%.

About Sysmex Corporation

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Compare Sysmex Corporation

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$502.94B
EBITDA
$117.26B
Profit Margin
8.90%
EPS (TTM)
0.47
Book Value
5.04

Technical Indicators

52 Week High
$17.31
52 Week Low
$8.43
50 Day MA
$9.15
200 Day MA
N/A
Beta
0.66

Valuation

Trailing P/E
17.94
Forward P/E
N/A
Price/Sales
0.01
Price/Book
1.67
Enterprise Value
$1.11B